email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
166 - 180
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Coherus Sets US Price of Junshi-Developed PD-1 at 20% Discount to Merck’s Keytruda
$5.00
Available
GenFleet Reports KRAS G12C Inhibitor is Under Review in China for NSCLC Approval
$5.00
Available
Accutar to Apply its AI Platform to Discover Inflammatory Disease Therapies with Evommune
$5.00
Available
Everest Approved to Launch Nefecon in China for Rare Kidney Disease
$5.00
Available
Korea’s DxVx Plans Novel Cancer Vaccine In-licensing from its Partner Oxford Vacmedix
$5.00
Available
Gracell to Start US Phase I/II Trial of Lead CAR-T for Lupus
$5.00
Available
Zhifei Biological to Acquire Chongqing Chenan Bio, a Diabetes/Obesity Company
$5.00
Available
AstraZeneca to Build Hong Kong R&D Center for Cell and Gene Therapies
$5.00
Available
Usynova Out-Licenses KRASG12D Inhibitor to AstraZeneca in $419 Million Agreement
$5.00
Available
Myriex Bio Acquires Antibody for Novel ADCs Discovered by WuXi Biologics
$5.00
Available
BeiGene Acquires Global Rights to CDK2 Inhibitor from Ensem in $1.3 Billion Deal
$5.00
Available
Simcere Signs $141 Million Deal for Connect Bio’s Novel Atopic Dermatitis Therapy
$5.00
Available
Porton Advanced and Ascle Therapeutics Collaborate on CAR-NK Cell Therapy
$5.00
Available
Haisco Out-Licenses Global Ex-China Rights for Bronchiectasis Therapy to Italy’s Chiesi Farma
$5.00
Available
WuXi XDC Raises $520 Million in IPO; Climbs 39% in First Trading Session
$5.00
Available